RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,326 | -59.6% | 271,484 | -5.3% | 0.00% | – |
| Q2 2023 | $315,404 | -43.6% | 286,731 | -39.0% | 0.00% | – |
| Q1 2023 | $559,486 | -5.8% | 470,157 | +17.9% | 0.00% | – |
| Q4 2022 | $594,134 | -7.9% | 398,748 | +0.9% | 0.00% | – |
| Q3 2022 | $645,000 | +103.5% | 395,378 | -0.9% | 0.00% | – |
| Q2 2022 | $317,000 | -53.7% | 399,040 | +4.8% | 0.00% | – |
| Q1 2022 | $685,000 | +0.6% | 380,829 | -4.5% | 0.00% | – |
| Q4 2021 | $681,000 | -14.6% | 398,899 | +3.1% | 0.00% | – |
| Q3 2021 | $797,000 | -0.4% | 386,935 | +11.7% | 0.00% | – |
| Q2 2021 | $800,000 | -79.6% | 346,556 | -75.3% | 0.00% | – |
| Q1 2021 | $3,920,000 | +1.6% | 1,405,038 | +3.8% | 0.00% | – |
| Q4 2020 | $3,857,000 | +39.3% | 1,353,018 | +2.7% | 0.00% | – |
| Q3 2020 | $2,768,000 | -54.0% | 1,317,460 | -0.3% | 0.00% | – |
| Q2 2020 | $6,013,000 | -45.1% | 1,321,593 | -1.4% | 0.00% | -100.0% |
| Q1 2020 | $10,957,000 | -56.1% | 1,341,025 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $24,932,000 | +71.3% | 1,360,118 | +3.6% | 0.00% | 0.0% |
| Q3 2019 | $14,552,000 | +10.7% | 1,313,339 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $13,142,000 | +99.4% | 1,292,173 | +14.9% | 0.00% | – |
| Q1 2019 | $6,592,000 | -19.6% | 1,124,827 | -2.6% | 0.00% | – |
| Q4 2018 | $8,199,000 | +5.6% | 1,154,815 | +5.7% | 0.00% | – |
| Q3 2018 | $7,764,000 | +35.1% | 1,092,028 | -4.6% | 0.00% | – |
| Q2 2018 | $5,747,000 | -41.8% | 1,144,988 | +27.6% | 0.00% | – |
| Q1 2018 | $9,880,000 | +5.6% | 897,429 | -11.3% | 0.00% | – |
| Q4 2017 | $9,359,000 | +4.4% | 1,011,855 | +1.4% | 0.00% | – |
| Q3 2017 | $8,961,000 | +30.4% | 998,056 | +2.1% | 0.00% | – |
| Q2 2017 | $6,873,000 | +170.4% | 977,590 | +236.1% | 0.00% | – |
| Q1 2017 | $2,542,000 | – | 290,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |